EGCG inhibits recepteur d'origine nantais expression by suppressing Egr-1 in gastric cancer cells

International Journal of Oncology

Volumn 42, Issue 3, 2013, Pages 1120-1126

  Park, Jung Sun ^a   Khoi, Pham Ngoc ^a   Joo, Young Eun ^a   Lee, Young Han ^b   Lang, Sven A ^c   Stoeltzing, Oliver ^d   Jung, Young Do ^a  

^a Chonnam National University   (South Korea)

^b Konkuk University   (South Korea)

^c UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^d UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Egr 1; Epigallocatechin 3 gallate; Gastric cancer; Recepteur d'origine nantais

Indexed keywords

EPIGALLOCATECHIN GALLATE; PHORBOL 13 ACETATE 12 MYRISTATE; RECEPTEUR D'ORIGINE NANTAIS; SCATTER FACTOR RECEPTOR; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BINDING SITE; CANCER CELL; CANCER GROWTH; CANCER INHIBITION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA BINDING; DOWN REGULATION; DRUG RESPONSE; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SITE DIRECTED MUTAGENESIS; STOMACH CANCER; TEA;

ANIMALS; CATECHIN; CELL LINE, TUMOR; DNA-BINDING PROTEINS; EARLY GROWTH RESPONSE PROTEIN 1; ENZYME ACTIVATION; HUMANS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM INVASIVENESS; NEOPLASM TRANSPLANTATION; PLANT EXTRACTS; PROMOTER REGIONS, GENETIC; RECEPTOR PROTEIN-TYROSINE KINASES; RNA INTERFERENCE; RNA, SMALL INTERFERING; STOMACH NEOPLASMS; TEA; TETRADECANOYLPHORBOL ACETATE; TRANSCRIPTION, GENETIC; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84873639014     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2013.1775     Document Type: Article

References (34)

1. Sasazuki S, Tamakoshi A, Matsuo K, Ito H, Wakai K, Nagata C, Mizoue T, Tanaka K, Tsuji I, Inoue M and Tsugane S; Research Group for the Development and Evaluation of Cancer Prevention Strategies in Japan: Green tea consumption and gastric cancer risk: an evaluation based on a systematic review of epidemiologic evidence among the Japanese population. Jpn J Clin Oncol 42: 335-346, 2012.
2. Yuan JM, Sun C and Butler LM: Tea and cancer prevention: epidemiological studies. Pharmacol Res 64: 123-135, 2011.
3. Stoner GD and Mukhtar H: Polyphenols as cancer chemopreventive agents. J Cell Biochem (Suppl) 22: 169-180, 1995.
4. Yoo HG, Shin BA, Park JC, Kim HS, Kim WJ, Chay KO, Ahn BW, Park RK, Ellis LM and Jung YD: Induction of apoptosis by the green tea flavonol (-)-epigallocatechin-3-gallate in human endothelial ECV 304 cells. Anticancer Res 22: 3373-3378, 2002. (Pubitemid 36070115)
5. Jung YD, Kim MS, Shin BA, Chay KO, Ahn BW, Liu W, Bucana CD, Gallick GE and Ellis LM: EGCG, a major component of green tea, inhibits tumour growth by inhibiting VEGF induction in human colon carcinoma cells. Br J Cancer 84: 844-850, 2001. (Pubitemid 32275661)
6. Nagini S: Carcinoma of the stomach: A review of epidemiology, pathogenesis, molecular genetics and chemoprevention. World J Gastrointest Oncol 4: 156-169, 2012.
7. Park JS, Park JH, Khoi PN, Joo YE and Jung YD: MSP-induced RON activation upregulates uPAR expression and cell invasiveness via MAPK, AP-1 and NF-κB signals in gastric cancer cells. Carcinogenesis 32: 175-181, 2011.
8. Feres KJ, Ischenko I and Hayman MJ: The RON receptor tyrosine kinase promotes MSP-independent cell spreading and survival in breast epithelial cells. Oncogene 28: 279-288, 2009.
9. Wang MH, Ronsin C, Gesnel MC, Coupey L, Skeel A, Leonard EJ and Breathnach R: Identification of the ron gene product as the receptor for the human macrophage stimulating protein. Science 266: 117-119, 1994. (Pubitemid 24345331)
10. Chen YQ, Zhou YQ, Angeloni D, Kurtz AL, Qiang XZ and Wang MH: Overexpression and activation of the RON receptor tyrosine kinase in a panel of human colorectal carcinoma cell lines. Exp Cell Res 261: 229-238, 2000.
11. Wang J, Rajput A, Kan JL, Rose R, Liu XQ, Kuropatwinski K, Hauser J, Beko A, Dominquez I, Sharratt EA, Brattain L, Levea C, Sun FL, Keane DM, Gibson NW and Brattain MG: Knockdown of Ron kinase inhibits mutant phosphatidylinositol 3-kinase and reduces metastasis in human colon carcinoma. J Biol Chem 284: 10912-10922, 2009.
12. Leonis MA, Thobe MN and Waltz SE: Ron-receptor tyrosine kinase in tumorigenesis and metastasis. Future Oncol 3: 441-448, 2007. (Pubitemid 47250161)
13. Thangasamy A, Rogge J and Ammanamanchi S: Recepteur d'origine nantais tyrosine kinase is a direct target of hypoxia-inducible factor-1alpha-mediated invasion of breast carcinoma cells. J Biol Chem 284: 14001-14010, 2009.
14. Lee KE, Park JS, Khoi PN, Joo YE, Lee YH and Jung YD: Upregulation of recepteur d'origine nantais tyrosine kinase and cell invasiveness via early growth response-1 in gastric cancer cells. J Cell Biochem 113: 1217-1223, 2012.
15. Thangasamy A, Rogge J and Ammanamanchi S: Regulation of RON tyrosine kinase-mediated invasion of breast cancer cells. J Biol Chem 283: 5335-5343, 2008.
16. Zhou D, Pan G, Zheng C, Zheng J, Yian L and Teng X: Expression of the RON receptor tyrosine kinase and its association with gastric carcinoma versus normal gastric tissues. BMC Cancer 8: 353, 2008.
17. Kono S, Ikeda M, Tokudome S and Kuratsune M: A case-control study of gastric cancer and diet in northern Kyushu, Japan. Jpn J Cancer Res 79: 1067-1074, 1988.
18. Rogers AE, Hafer LJ, Iskander YS and Yang S: Black tea and mammary gland carcinogenesis by 7, 12-dimethylbenz(a)anthracene in rats fed control or high fat diets. Carcinogenesis 19: 1269-1273, 1998. (Pubitemid 28375379)
19. Fujiki H, Suganuma M, Okabe S, Sueoka E, Suga K, Imai K, Nakachi K and Kimura S: Mechanistic findings of green tea as cancer preventive for humans. Proc Soc Exp Biol Med 220: 225-228, 1999.
20. Liang YC, Lin-shiau SY, Chen CF and Lin JK: Suppression of extracellular signals and cell proliferation through EGF receptor binding by (-)-epigallocatechin gallate in human A431 epdeidermoid carcinoma cells. J Cell Biochem 67: 55-65, 1997.
21. Kitano K, Nam KY, Kimura S, Fujiki H and Imanishi Y: Sealing effects of (-)-epigallocatechin gallate on protein kinase C and protein phosphatase 2A. Biophys Chem 65: 157-164, 1997. (Pubitemid 27199419)
22. Fu Y and Chen A: The phyto-chemical (-)-epigallocatechin gallate suppresses gene expression of epidermal growth factor receptor in rat hepatic stellate cells in vitro by reducing the activity of Egr-1. Biochem Pharmacol 72: 227-238, 2006. (Pubitemid 43850434)
23. Moon Y, Lee M and Yang H: Involvement of early growth response gene 1 in the modulation of microsomal prostaglandin E synthase 1 by epigallocatechin gallate in A549 human pulmonary epithelial cells. Biochem Pharmacol 73: 125-135, 2007. (Pubitemid 44868978)
24. Thiel G and Cibelli G: Regulation of life and death by the zinc finger transcription factor Egr-1. J Cell Physiol 193: 287-292, 2002. (Pubitemid 35265949)
25. Shin SY, Kim JH, Baker A, Lim Y and Lee YH: Transcription factor Egr-1 is essential for maximal matrix metalloproteinase-9 transcription by tumor necrosis factor alpha. Mol Cancer Res 8: 507-519, 2010.
26. Keates S, Keates AC, Nath S, Peek RM Jr and Kelly CP: Transactivation of the epidermal growth factor receptor by cag+ Helicobacter pylori induces upregulation of the early growth response gene Egr-1 in gastric epithelial cells. Gut 54: 1363-1369, 2005. (Pubitemid 41375187)
27. Ma J, Ren Z, Ma Y, Xu L, Zhao Y, Zheng C, Fang Y, Xue T, Sun B and Xiao W: Targeted knockdown of EGR-1 inhibits IL-8 production and IL-8-mediated invasion of prostate cancer cells through suppressing EGR-1/NF-kappaB synergy. J Biol Chem 284: 34600-34606, 2009.
28. Kaufmann K and Thiel G: Epidermal growth factor and platelet-derived growth factor induce expression of Egr-1, a zinc finger transcription factor, in human malignant glioma cells. J Neurol Sci 189: 83-91, 2001. (Pubitemid 32776653)
29. Cohen DM, Gullans SR and Chin WW: Urea inducibility of egr-1 in murine inner medullary collecting duct cells is mediated by the serum response element and adjacent Ets motifs. J Biol Chem 271: 12903-12908, 1996. (Pubitemid 26175863)
30. Katiyar SK, Afaq F, Azizuddin K and Mukhtar H: Inhibition of UVB-induced oxidative stress-mediated phosphorylation of mitogen-activated protein kinase signaling pathways in cultured human epidermal keratinocytes by green tea polyphenol (-)-epigallocatechin-3-gallate. Toxicol Appl Pharmacol 176: 110-117, 2001. (Pubitemid 33015861)
31. Khan HY, Zubair H, Ullah MF, Ahmad A and Hadi SM: Oral administration of copper to rats leads to increased lymphocyte cellular DNA degradation by dietary polyphenols: implications for a cancer preventive mechanism. Biometals 24: 1169-1178, 2011.
32. Lin JK: Cancer chemoprevention by tea polyphenols through modulating signal transduction pathways. Arch Pharm Res 25: 561-571, 2002.
33. O'Toole JM, Rabenau KE, Burns K, Lu D, Mangalampalli V, Balderes P, Covino N, Bassi R, Prewett M, Gottfredsen KJ, Thobe MN, Cheng Y, Li Y, Hicklin DJ, Zhu Z, Waltz SE, Hayman MJ, Ludwig DL and Pereira DS: Therapeutic implications of a human neutralizing antibody to the macrophage-stimulating protein receptor tyrosine kinase (RON), a c-MET family member. Cancer Res 66: 9162-9170, 2006. (Pubitemid 44521136)
34. Logan-Collins J, Thomas RM, Yu P, Jaquish D, Mose E, French R, Stuart W, McClaine R, Aronow B, Hoffman RM, Waltz SE and Lowy AM: Silencing of RON receptor signaling promotes apoptosis and gemcitabine sensitivity in pancreatic cancers. Cancer Res 70: 1130-1140, 2010.